Ear Keloid Removal & Management Melbourne

A keloid that is actively itchy, tender, or painful is almost always a sign that it is biologically active — inflammation is ongoing within the scar tissue, fibroblast activity is elevated, and the keloid is likely still growing. Symptomatic keloids carry a significantly higher recurrence risk than asymptomatic ones and typically require a more intensive and prolonged post-treatment program.

Larger keloids contain a greater volume of abnormal fibroblasts and collagen — and leave a correspondingly larger wound bed following debulking. Larger maximum lesion diameter is a well-documented independent risk factor for keloid recurrence in the medical literature. Very large keloids may require more injection sessions over a longer period to achieve durable control.

Patients with multiple keloids — whether on the same ear or across multiple sites — often have a stronger underlying keloid-forming tendency than those with a single lesion. Multiple lesions reflect a more systemic predisposition, and each individual keloid may require its own treatment plan and monitoring schedule.

Keloid shape has a meaningful bearing on recurrence risk — and this is a nuance that is often overlooked. Pedunculated keloids (those with a defined stalk or neck) generally carry a lower recurrence risk following surgical debulking, because their base of attachment is narrower, the wound bed is more defined, and wound tension after excision is typically lower. Broad-based (sessile) keloids — which spread widely across the earlobe without a clear neck — are more challenging: they involve a larger wound area, healing is under greater tension, and the recurrence risk is correspondingly higher. Dumbbell or butterfly-shaped keloids — which pass through the piercing tunnel and involve both the front and back of the earlobe — are among the most complex morphologically, requiring careful treatment of both components and carrying a higher recurrence risk due to the anatomical tension and the extent of tissue involved. Dr Ed classifies every keloid by morphology at the initial consultation, and this directly informs the intensity and duration of the post-treatment program.

Recurrence is the central challenge in keloid management, and the honest answer is that keloids do carry a meaningful recurrence risk — particularly when treated with surgery alone. This is precisely why Dr Ed’s approach combines surgical debulking with a carefully planned, sustained injection program and adjuvant compression/silicone therapy. Studies consistently show that this multimodal approach achieves significantly lower recurrence rates than any single modality alone. Long-term monitoring following treatment completion also allows early re-treatment if any signs of regrowth appear.

Surgical debulking is performed under local anaesthetic, so you should not feel pain during the procedure itself — though you will feel pressure and awareness of movement. The injection of local anaesthetic itself produces a brief stinging sensation as it is administered. Intralesional steroid injections can be uncomfortable, as the tissue is being injected under pressure. Dr Ed uses techniques to minimise discomfort at each visit, and most patients find the injections very manageable in a clinical setting. If you have concerns about pain, please discuss this with Dr Ed at your consultation.

No GP referral is required to book a consultation at The DOC Clinic. You can book directly online or by calling the clinic on 03 9021 6022.

This depends significantly on the size, behaviour, and history of your keloid. A straightforward, first-time ear lobe keloid may be well-controlled within 4–6 months from the initial debulking procedure through to the completion of injection therapy. More complex, large, or recurrent keloids may require an active treatment period of 9–18 months, followed by an ongoing monitoring phase. Adjuvant silicone therapy and compression magnet use are recommended for a minimum of 6–12 months regardless of the size of the keloid. Dr Ed will provide a realistic individualised timeline at your consultation.

Re-piercing after keloid treatment is generally not recommended. Any new wound to the ear — including re-piercing — carries a significant risk of forming another keloid in an already keloid-prone individual. If re-piercing is important to you, this should be discussed in detail with Dr Ed, who can advise on timing, risk-reduction strategies (such as prophylactic injection at the time of piercing), and whether your specific case makes re-piercing a reasonable consideration.

Medical-grade ear compression magnets are considered safe for most patients. The magnetic field they generate is localised and very low-level. They should not be used by patients with pacemakers or certain metal implants — Dr Ed will screen for contraindications at your consultation. Potential issues include skin irritation or pressure sores if applied too tightly, or if worn continuously without daily hygiene care. Dr Ed will guide you on appropriate application technique and hygiene to avoid these problems.

Medicare rebates may be applicable for consultations and certain medically indicated keloid treatments. Purely cosmetic consultations are not Medicare rebatable. Dr Ed will assess your eligibility at your initial consultation. The DOC Clinic is a private billing clinic, and fees are charged in line with AMA recommended specialist rates. Full payment is required on the day. Please call the clinic to discuss fee arrangements in advance if you would like further guidance.

Both are effective and share the same primary mechanism — hydration of the scar surface to reduce fibroblast overactivity. Silicone gel is generally preferred on the ear because it conforms to curved surfaces, dries invisibly, and can be applied under other products. Silicone sheets provide a small additional compression effect and are highly effective on flatter or more accessible scars. For ear keloid management, Dr Ed typically recommends silicone gel as the primary silicone-based adjuvant, with sheets potentially used on more accessible scar margins or post-auricular areas. The most important factor is consistent daily use for the recommended duration — at least 3 months, and ideally 6–12 months.

Yes. Recurrent keloids are a significant part of Dr Ed’s practice. A detailed history of your previous treatment — including what was done, when, and how the keloid responded — is important information that will inform the new management plan. Recurrent keloids can often still be effectively managed, though they may require a more intensive or prolonged treatment course. Please bring any relevant documentation or photographs from your previous treatment to your consultation if available.